| Old Articles: <Older 6281-6290 Newer> |
|---|
 |
The Motley Fool
April 9, 2010
Brian Orelli |
Double Your Biotech Returns! Really! Taking a closer look at leveraged biotech ETFs.   |
BusinessWeek
April 8, 2010
Margaret Collins |
Stealing Your Identity for Liposuction Crooks are using pilfered data to charge health care - from cosmetic surgery to emergency room visits. |
BusinessWeek
April 8, 2010
Arlene Weintraub |
Diabetes Is No Fun, but It Can Be a Game Bayer hopes that partnering with Nintendo will make it the leader in glucose testing. |
InternetNews
April 8, 2010 |
Unencrypted Patient Data Lost in Laptop Theft Once again, lost notebook PCs have exposed the data of thousands of health care patients. |
The Motley Fool
April 8, 2010
Brian Orelli |
Is Icahn Stuck in the Station? Saving Genzyme's train wreck may be difficult. |
The Motley Fool
April 7, 2010
Rick Steier |
Is Teva Pharmaceutical a Forever Hold? Teva is a compelling reason why investors should look abroad for opportunity. |
The Motley Fool
April 7, 2010
Brian Orelli |
Teva: Hold Until Things Turn Ugly Despite the drugmaker's recent success, its future looks precarious. |
The Motley Fool
April 6, 2010
Brian Orelli |
Kill It! Double-Teaming Malaria Malaria vaccine might not make Glaxo and Crucell rich, but the life-saving and PR benefits would be welcome. |
The Motley Fool
April 5, 2010
Brian Orelli |
Up 30%? What Are You People On? Fast-track designations aren't worth much more than the paper they're printed on. |
The Motley Fool
April 5, 2010
Brian Orelli |
1 Month to Go! Is Dendreon a Buy? Only if you understand the risks. |
| <Older 6281-6290 Newer> Return to current articles. |
